SE9302013L - Method for determining HbA 1C and composition for carrying out the process - Google Patents

Method for determining HbA 1C and composition for carrying out the process

Info

Publication number
SE9302013L
SE9302013L SE9302013A SE9302013A SE9302013L SE 9302013 L SE9302013 L SE 9302013L SE 9302013 A SE9302013 A SE 9302013A SE 9302013 A SE9302013 A SE 9302013A SE 9302013 L SE9302013 L SE 9302013L
Authority
SE
Sweden
Prior art keywords
composition
carrying
determining
blood
dried
Prior art date
Application number
SE9302013A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE9302013D0 (en
SE504914C2 (en
Inventor
Jan O Jeppsson
Original Assignee
Boehringer Mannheim Scandinavi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Scandinavi filed Critical Boehringer Mannheim Scandinavi
Priority to SE9302013A priority Critical patent/SE504914C2/en
Publication of SE9302013D0 publication Critical patent/SE9302013D0/en
Priority to AU70123/94A priority patent/AU7012394A/en
Priority to PCT/SE1994/000564 priority patent/WO1994029730A1/en
Publication of SE9302013L publication Critical patent/SE9302013L/en
Publication of SE504914C2 publication Critical patent/SE504914C2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for determining the HbA1c content in blood which is dried in an absorbing material is disclosed. The dried blood is treated with a cysteine solution for eliminating the interfering HbA3 fraction and reducing the amount of methaemoglobin, whereupon the HbA1c content is determined. According to one embodiment, the absorbing material with the dried blood is pretreated with a buffer solution. A composition for the treatment is also disclosed. The composition comprises a buffered cysteine solution.
SE9302013A 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process SE504914C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (en) 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process
AU70123/94A AU7012394A (en) 1993-06-11 1994-06-10 Method for determining hba1c, and composition for implementing the method
PCT/SE1994/000564 WO1994029730A1 (en) 1993-06-11 1994-06-10 METHOD FOR DETERMINING HbA1c, AND COMPOSITION FOR IMPLEMENTING THE METHOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (en) 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process

Publications (3)

Publication Number Publication Date
SE9302013D0 SE9302013D0 (en) 1993-06-11
SE9302013L true SE9302013L (en) 1994-12-12
SE504914C2 SE504914C2 (en) 1997-05-26

Family

ID=20390247

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302013A SE504914C2 (en) 1993-06-11 1993-06-11 Method for determining HbA1C and composition for carrying out the process

Country Status (3)

Country Link
AU (1) AU7012394A (en)
SE (1) SE504914C2 (en)
WO (1) WO1994029730A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE444491T1 (en) 2005-05-20 2009-10-15 Germediq Forsch & Entw Ges Mbh METHOD FOR DETERMINING CARDIOVASCULAR RISK FACTORS
CN106033076A (en) * 2015-03-18 2016-10-19 杭州量康科技有限公司 Method and system for detecting dried blood sample

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments

Also Published As

Publication number Publication date
AU7012394A (en) 1995-01-03
SE9302013D0 (en) 1993-06-11
SE504914C2 (en) 1997-05-26
WO1994029730A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
ATE223044T1 (en) DETECTION OF RETICULOCYTES WITH CORIPHOSPHIN O
EE9700225A (en) A method of treating diabetes mellitus using KKF
FI871288A0 (en) Process for Preparation of Aprotinin by Recombinant DNA Technology and in the Method Useful DNA, Expression Plasmid and Host Cell
DK336987D0 (en) immobilization
EA199900725A1 (en) SYNERGETIC COMBINATIONS OF SULFONILM URINE AND GLITAZONE IN THE TREATMENT OF DIABETES
NO951740D0 (en) Preparations of oak bark extract, related synthetic preparations and methods for using them
SE8802781L (en) PROCEDURE FOR DEHUMATING GAS
DE3172043D1 (en) Derivatized agarose and method of making and using same
ATE125268T1 (en) ACID-SENSITIVE SUBUNIT OF AN INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN COMPLEX.
DK0407813T3 (en) Oxidative denaturation of protein analytes
DK1027207T3 (en) Process for treating an article containing an oxidizable organic compound
TW262536B (en)
DE59001435D1 (en) METHOD FOR NITROCARBURING STEEL COMPONENTS.
DE59308000D1 (en) IMMUNOASSAY FOR DETECTING COLLAGEN OR COLLAGEN FRAGMENTS
SE7904282L (en) PROCEDURE FOR DETECTING SCRAPS IN SAMPLES
KR940027658A (en) Thrombin binding material and preparation method thereof
ATE124539T1 (en) IMMUNOGEN AND ITS USE FOR OBTAINING ANTIBODIES AGAINST HBA1C.
GB1527268A (en) Antiserum for the quantitative determination of the decomposition products x and y of fibrin and fibrinogen
DE3474358D1 (en) Method of decreasing turbidity in control sera
SE9302013D0 (en) PROCEDURE FOR DETERMINATION OF HBA 1C AND COMPOSITION BEFORE IMPLEMENTATION OF THE PROCEDURE
DK0509980T3 (en) Process for, in particular, accelerated aerobic microbiological degradation of biological materials
ES2110998T3 (en) PROCEDURE FOR THE DETERMINATION OF THROMBOPENIAS.
PT1171578E (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING NKT CELLS ACTIVATED BY PIM AND ITS USE IN THERAPY
AR227320A1 (en) AN APPROPRIATE COMPOSITION FOR USE IN THE TREATMENT OF GLASS FIBERS, METHOD FOR TREATING SUCH FIBERS WITH THE ABOVE COMPOSITION, TREATED GLASS FIBERS, AND COMPOSITE BODY CONTAINING SUCH FIBERS
JPS6426520A (en) Stabilization of cell membrane and application to prevervation of cell in state protecting essence of antibody of cell membrane surface

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9302013-9

Format of ref document f/p: F